PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-31.28%
Both yoy net incomes decline, with TRVN at -82.60%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.30%
Some D&A expansion while TRVN is negative at -9.46%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
No Data
No Data available this quarter, please select a different quarter.
41.15%
SBC growth while TRVN is negative at -3.15%. John Neff would see competitor possibly controlling share issuance more tightly.
170.16%
Well above TRVN's 111.46% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
170.16%
Growth well above TRVN's 111.46%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
169.42%
Some yoy increase while TRVN is negative at -29.47%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-4.39%
Both yoy CFO lines are negative, with TRVN at -104.14%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
94.15%
CapEx growth of 94.15% while TRVN is zero at 0.00%. Bruce Berkowitz would see a mild cost burden that must yield returns in future revenue or margins.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Investing outflow well above TRVN's 49.82%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-97.06%
Negative yoy issuance while TRVN is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.